Frailty and Cancer Prognosis

Area of Science:

• Geriatric Oncology
• Clinical Epidemiology
• Cancer Survivorship

Background:

• Older adults with cancer represent a growing population with unique health challenges.
• Frailty is an emerging geriatric syndrome associated with adverse health outcomes.
• Understanding frailty's role is crucial for optimizing care in oncology.

Purpose of the Study:

• To review existing evidence on the prognostic significance of frailty in older cancer patients.
• To examine the prognostic implications of frailty in cancer survivors.

Main Methods:

• Systematic review of current scientific literature.
• Analysis of studies investigating frailty in diverse oncological settings.
• Exploration of frailty's impact on mortality, complications, and survivorship.

Main Results:

• Frailty is consistently linked to increased mortality, postoperative complications, and longer hospital stays in cancer patients.
• Evidence suggests frailty predicts treatment-related toxicity, although this area requires further research.
• In cancer survivors, frailty is a risk factor for cardiovascular disease, diabetes, mortality, cognitive decline, and symptom burden.

Conclusions:

• Frailty is a critical prognostic indicator in older cancer patients, influencing survival and treatment outcomes.
• Screening for frailty is valuable for prognosis and guiding treatment decisions in geriatric oncology.
• Frailty assessment is essential for managing long-term health in cancer survivors.